- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 94,120 | 22.07.24 11:57:45 | +1,780 | +1,93% | 94,250 | 94,300 | 92,760 | 92,340 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 970,000 | 22.07.24 11:57:26 | -12,400 | -1,26% | 970,600 | 976,600 | 972,000 | 982,400 |
